Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gareth R Evans

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Journal of Medical Genetics|February 1, 2011
Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onsetMiriam J Smith, Jenny E Higgs, Naomi L Bowers, et al.
Breast Cancer Research : BCR|May 29, 2016
Intermittent energy restriction induces changes in breast gene expression and systemic metabolismMichelle N Harvie, Andrew H Sims, Mary Pegington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutationsMiriam J Smith, Christian Beetz, Simon G Williams, et al.
Journal of Medical Genetics|August 16, 2015
Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patientsAdam Hexter, Adrian Jones, Harry Joe, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 15, 2012
Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer preventionD Gareth R Evans, Jane Warwick, Susan M Astley, et al.
Journal of Medical Genetics|January 27, 2019
Prevalence of germline pathogenic <i>BRCA1/2</i> variants in sequential epithelial ovarian cancer casesRobert D Morgan, George J Burghel, Nicola Flaum, et al.
Cancers|February 11, 2023
Is Reflex Germline <i>BRCA1/2</i> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?Robert D Morgan, George J Burghel, Nicola Flaum, et al.
British Journal of Cancer|March 9, 2022
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?Robert D Morgan, George J Burghel, Nicola Flaum, et al.
British Journal of Cancer|March 30, 2016
Breast cancer risk feedback to women in the UK NHS breast screening populationD Gareth R Evans, Louise S Donnelly, Elaine F Harkness, et al.
JAMA Oncology|October 4, 2019
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast CancerLi Sun, Adam Brentnall, Shreeya Patel, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Journal of Medical Genetics|February 1, 2011
Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onsetMiriam J Smith, Jenny E Higgs, Naomi L Bowers, et al.
Breast Cancer Research : BCR|May 29, 2016
Intermittent energy restriction induces changes in breast gene expression and systemic metabolismMichelle N Harvie, Andrew H Sims, Mary Pegington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutationsMiriam J Smith, Christian Beetz, Simon G Williams, et al.
Journal of Medical Genetics|August 16, 2015
Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patientsAdam Hexter, Adrian Jones, Harry Joe, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 15, 2012
Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer preventionD Gareth R Evans, Jane Warwick, Susan M Astley, et al.
Journal of Medical Genetics|January 27, 2019
Prevalence of germline pathogenic <i>BRCA1/2</i> variants in sequential epithelial ovarian cancer casesRobert D Morgan, George J Burghel, Nicola Flaum, et al.
Cancers|February 11, 2023
Is Reflex Germline <i>BRCA1/2</i> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?Robert D Morgan, George J Burghel, Nicola Flaum, et al.
British Journal of Cancer|March 9, 2022
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?Robert D Morgan, George J Burghel, Nicola Flaum, et al.
British Journal of Cancer|March 30, 2016
Breast cancer risk feedback to women in the UK NHS breast screening populationD Gareth R Evans, Louise S Donnelly, Elaine F Harkness, et al.
JAMA Oncology|October 4, 2019
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast CancerLi Sun, Adam Brentnall, Shreeya Patel, et al.
Pageof 11